等待开盘 04-01 09:30:00 美东时间
-6.350
-23.10%
今日重点评级关注:古根海姆:维持Dianthus Therapeutics"买入"评级,目标价从100美元升至200美元;HC Wainwright & Co.:维持Amylyx Pharmaceuticals"买入"评级,目标价从28美元升至34美元
03-05 13:56
Canaccord Genuity analyst Luke Morison maintains Advantage Solutions (NASDAQ:ADV) with a Buy and lowers the price target from $2.5 to $1.5.
03-05 02:56
Advantage Solutions (NASDAQ:ADV) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.03) by 1566.67 percent. This is a 5100 percent decrease over earnings of $0.01 per share
03-03 20:12
Advantage Solutions (NASDAQ:ADV) announced its Q4 earnings on Tuesday, March 3,...
03-03 20:10
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Morgan Stanley analyst Toni Kaplan maintains Advantage Solutions (NASDAQ:ADV) with a Equal-Weight and lowers the price target from $2 to $1.5.
2025-12-17 21:46
Genpact demonstrates excellence in enabling agentic enterprise transformation within Salesforce ecosystem NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Genpact (NYSE: G), an agentic and advanced t...
2025-11-13 21:05
Advantage Solutions (NASDAQ:ADV) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.03) by 340 percent. This is a 250 percent increase over losses of $(0.04) per share from
2025-11-06 20:04
<p>Advantage Solutions Inc. announced it will release third-quarter financial results on November 6, 2025, at 7 a.m. EDT, followed by a conference call at 8:30 a.m. EDT. Call details are provided for U.S. and international callers, with a replay available three hours post-call. A webcast option is also available through the company’s Investor Relations website. Advantage Solutions is a leading retail solutions agency in North America, offering da...
2025-10-24 11:00